Papillary thyroid cancer recurrence 43 Years following Total Thyroidectomy and radioactive iodine ablation: A case report

被引:12
作者
Amoako-Tuffour Y. [1 ]
Graham M.E. [2 ]
Bullock M. [3 ]
Rigby M.H. [2 ]
Trites J. [2 ]
Taylor S.M. [2 ]
Hart R.D. [2 ]
机构
[1] Department of Diagnostic Radiology, Dalhousie University PO-BOX-9000, Floor Victoria Building, VG Site, QEII Health Sciences Centre, 1276 South Park Street, Halifax, B3H 2Y9, NS
[2] Division of Otolaryngology - Head and Neck Surgery, Dalhousie University, 3rd Floor Dickson Building, VG Site, QEII Health Sciences Centre, 5820 University Ave, Halifax, B3H 2Y9, NS
[3] Department of Anatomical Pathology, Dalhousie University, 1459 Oxford Street, Halifax, B3H 4R2, NS
关键词
Case report; Neck dissection; Papillary thyroid cancer; Radioiodine ablation; Recurrence; Thyroidectomy;
D O I
10.1186/s13044-017-0043-4
中图分类号
学科分类号
摘要
Background: Recurrent papillary thyroid carcinoma (PTC) beyond the first two decades of definitive treatment (i.e. total thyroidectomy and radioactive iodine ablation) is a rare occurrence. Case presentation: We present a case of a 71-year old Caucasian female with a distant history of PTC treated with total thyroidectomy and radioactive iodine ablation who experienced recurrence of her disease 43 years following initial diagnosis and definitive treatment. She presented with palpable left-sided neck mass and subsequently underwent a level II, III, neck dissection and adjuvant iodine ablation. This case presents the latest recurrence in papillary thyroid cancer documented to date in the literature. Conclusion: This case exemplifies the need for the head and neck surgeon, radiation oncologist, general practitioner and radiologist to consider new lateral neck mass as late-presenting recurrence of PTC until proven otherwise regardless of low recurrence rates beyond two decades from treatment and low prognostic risk scores. © 2017 The Author(s).
引用
收藏
相关论文
共 16 条
[1]  
Roh J.L., Park J.Y., Rha K.S., Park C.I.I., Central neck dissection necessary for the treatment of lateral cervical nodal recurrence of papillary thyroid carcinoma?, Head & Neck, 29, 10, pp. 901-906, (2007)
[2]  
Hay I.D., Thompson G.B., Grant C.S., Bergstralh E.J., Dvorak C.E., Gorman C.A., Et al., Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients, World J Surg, 26, 8, pp. 879-885, (2002)
[3]  
Schlumberger M.J., Papillary and follicular thyroid carcinoma, N Engl J Med, 338, 5, pp. 297-306, (1998)
[4]  
Sherma S.I., Thyroid carcinoma, Lancet, 361, 9356, pp. 501-511, (2003)
[5]  
Siegel R., Ma J., Zou Z., Jemal A., Cancer statistics, 2014, CA Cancer J Clin, 64, 1, pp. 9-29, (2014)
[6]  
Hay I.D., Grant C.S., Bergstralh E.J., Thompson G.B., Van Heerden J.A., Goellner J.R., Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma?, Surgery, 124, 6, pp. 958-966, (1998)
[7]  
Cirocchi R., Trastulli S., Sanguinetti A., Cattorini L., Covarelli P., Giannotti D., Et al., Recurrent differentiated thyroid cancer: To cut or burn, World J Surg Oncol, 9, (2011)
[8]  
Cady B., Rossi R., An expanded view of risk-group definition in differentiated thyroid carcinoma, Surgery, 104, 6, pp. 947-953, (1988)
[9]  
Schlumberger M., De Vathaire F., Travagli J., Vassal G., Lemerle J., Parmentier C., Et al., Differentiated thyroid carcinoma in childhood: Long term follow-up of 72 patients, The Journal of Clinical Endocrinology & Metabolism., 65, 6, pp. 1088-1094, (1987)
[10]  
Grogan R.H., Kaplan S.P., Cao H., Weiss R.E., Degroot L.J., Simon C.A., Et al., A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up, Surgery, 154, 6, pp. 1436-1447, (2013)